chartexchange

Allucent Appoints Chief Medical Officer and Infectious Disease Therapeutic Strategy Head

PR Newswire | Nov 10, 2026 7:30 AM EST

Hubert Bland and Norman Waters strengthen Allucent's specialized expertise and integrated support for life cycle drug development CARY, N.C., Nov. 10, 2026 /PRNewswire/ -- Allucent, a global specialty CRO purpose-built for small and mid-sized biopharma companies, today announced the...

Read original article